Catalyst

Slingshot members are tracking this event:

ACADIA Pharma initiates $300M equity offering (10,000,000 Shares)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
ACAD

100%

Additional Information

Additional Relevant Details Price, volume and terms have yet to be announced. Acadia intends to use the proceeds from the offering principally to fund its acquisition strategy, particularly to fund a portion of the purchase price for its planned acquisition of the Priory Group, a leading provider of behavioral healthcare services in the United Kingdom, and the fees and expenses related to the transaction. In connection with the offering, Acadia intends to grant to the underwriters a 30-day option to purchase up to an additional 15% of its common stock issued in the offering.
http://phx.corporate...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 05, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Equity Offering, Initiation